TY - JOUR AU - Saiphoklang, Narongkorn AU - Rittayamai , Nuttapol PY - 2021/10/29 Y2 - 2024/03/29 TI - COVID-19 and Pulmonary Involvement JF - Asian Medical Journal and Alternative Medicine JA - AMJAM VL - 21 IS - - SE - Review Articles DO - UR - https://asianmedjam.com/index.php/amjam/article/view/302 SP - S81-S90 AB - <p>The COVID-19 pandemic results in the largest global health crisis. Most patients are asymptomatic. Pneumonia usually develops in about one week after infection, with approximately 5% of patients needing ICU admission due to hypoxemia or acute respiratory failure. The common symptoms of patients with COVID-19 pneumonia are fever, cough, and sputum production. Typical radiographic features of pneumonia are bilateral lower lobe lesions with ground-glass opacities or consolidations. N95 respirator in combination with personal protective equipment are necessary to prevent COVID-19 from spreading among healthcare workers during aerosol-generating procedures. Hemodynamic and ventilation management of critically ill patients with COVID-19 should follow established guidelines. Remdesivir and dexamethasone are beneficial in hospitalized patients with COVID-19 pneumonia who require supplemental oxygen or mechanical ventilation. Favipiravir can reduce the duration of hospital stay and time for clinical treatment in <br>hospitalized COVID-19 patients. Evidence regarding the benefits of other medications remains conflicting.</p> ER -